Transdermal drug administration device
AssigneeEmplicure AB
InventorsHåkan Engqvist, Susanne Bredenberg, Anders Petterson, Thomas Lundqvist, Anna Dahlgren, Anders Sågström
Life of this patent
Estimating the term…
Abstract
A transdermal drug administration device comprising a drug delivery element (10) defining a contact surface (12) for location, in use, against a patient's skin. The drug delivery element (10) includes a sustained-release pharmaceutical composition. The composition comprises a network of a carrier material having a high mechanical strength and an active pharmaceutical ingredient. The active pharmaceutical ingredient is co-formedly interspersed within pores in the solid, continuous network of the carrier material.
Claims27
An abuse-resistant transdermal drug administration device comprising a drug delivery element defining a contact surface for location, in use, against a patient's skin, the drug delivery element including a sustained-release pharmaceutical composition comprising one or more active pharmaceutical ingredients co-formedly interspersed within pores of a solid, continuous network comprising a carrier material and possessing a high mechanical strength, wherein said one or more active pharmaceutical ingredients includes a substance that is open to abuse potential.
A transdermal drug administration device according to claim 28 wherein the one or more active pharmaceutical ingredients includes an opioid analgesic.
A transdermal drug administration device according to claim 28 wherein the opioid analgesic is a morphinan derivative, a benzomorphan derivative, a phenylpiperidine, a phenylheptamine, an open chain compound, a diphenylpropylamine derivative, a mixed agonist/antagonist or another synthetic opioid.
24-26. (canceled)
Dependencies are inferred from the claim text.